Concord Medical Services Holdings Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of July 2026 for Concord Medical Services Holdings Limited (NYSE: CCM), a healthcare provider specializing in cancer treatment, research, education, and prevention in China. The report was signed by Chairman and CEO Jianyu Yang on July 2, 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure regarding management changes and does not contain financial statements or performance metrics.
Material Changes
- Resignation of CFO: Mr. Wei Jiang stepped down as Chief Financial Officer effective June 30, 2026.
- Reason for Departure: Mr. Jiang resigned to focus on the business and operations of Concord Healthcare Group Co., Ltd. (2453.HK), a subsidiary of the Company.
- No Disagreement: The resignation did not result from any disagreement regarding operations, policies, practices, or financial reporting.
- Interim Appointment: Mr. Botao Shi was appointed as Interim Chief Financial Officer effective June 30, 2026.
Outlook, Risks, and Management Commentary
CEO Dr. Jianyu Yang expressed gratitude for Mr. Jiang's contributions and confidence in working with Mr. Shi to create shareholder value. Mr. Shi brings extensive experience, having served as Vice President and Board Secretary since August 2024 and holding various roles within the Concord group since 2007. The filing includes standard forward-looking statements regarding risks and uncertainties that may cause actual results to differ from expectations.
Key Facts for Investor Verification
- Verify the transition timeline and handover status between the outgoing and interim CFO.
- Confirm Mr. Botao Shi's specific background in financial reporting and capital markets to ensure continuity.
- Monitor future filings for the appointment of a permanent CFO.
- Review the operational status of the subsidiary, Concord Healthcare Group, given the CFO's shift in focus.